VAERS Explorer
Back to explore

Report #2840565

Received May 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
MA
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNKY3Z9P—

Symptoms (1)

Incorrect dose administered

Symptom narrative

Boostrix incomplete dose administration; This non-serious case was reported by a nurse via call center representative and described the occurrence of incomplete dose administered in a 47-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number Y3Z9P, expiry date 27-AUG-2027) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incomplete dose administered (Verbatim: Boostrix incomplete dose administration). The outcome of the incomplete dose administered was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 02-MAY-2025 The registered nurse reported that the patient received incomplete dose of Boostrix. The nurse wanted to know how to proceed (like repeat the dose in two or four weeks or wait at al) after a patient received an incomplete dose of Boostrix. The vaccine administration facility was the same as primary reporter.